Gunnar Boysen
Concepts (344)
Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Butadienes | 16 | 2022 | 50 | 4.300 |
Why?
| Tandem Mass Spectrometry | 17 | 2019 | 248 | 2.860 |
Why?
| Epoxy Compounds | 12 | 2021 | 48 | 2.690 |
Why?
| DNA Adducts | 13 | 2021 | 162 | 2.060 |
Why?
| Chromatography, Liquid | 13 | 2020 | 243 | 2.030 |
Why?
| Carcinogens | 8 | 2022 | 231 | 2.020 |
Why?
| Lung Neoplasms | 5 | 2024 | 642 | 1.870 |
Why?
| Hemoglobins | 8 | 2022 | 126 | 1.810 |
Why?
| Valine | 7 | 2019 | 54 | 1.690 |
Why?
| Cytochrome P-450 CYP2E1 | 6 | 2017 | 105 | 1.630 |
Why?
| Glutathione | 7 | 2021 | 330 | 1.480 |
Why?
| Guanine | 7 | 2018 | 42 | 1.290 |
Why?
| DNA | 10 | 2021 | 581 | 1.210 |
Why?
| Microsomes, Liver | 12 | 2021 | 214 | 1.190 |
Why?
| Radiation Tolerance | 2 | 2019 | 86 | 1.160 |
Why?
| Biotin | 5 | 2014 | 45 | 1.160 |
Why?
| Chromatography, High Pressure Liquid | 12 | 2021 | 377 | 1.010 |
Why?
| Spectrometry, Mass, Electrospray Ionization | 7 | 2010 | 67 | 0.880 |
Why?
| Thiadiazoles | 2 | 2019 | 15 | 0.820 |
Why?
| Metabolome | 2 | 2021 | 109 | 0.750 |
Why?
| Metabolomics | 1 | 2021 | 149 | 0.750 |
Why?
| Cisplatin | 4 | 2024 | 352 | 0.740 |
Why?
| Glutathione Transferase | 1 | 2020 | 178 | 0.730 |
Why?
| Busulfan | 1 | 2019 | 18 | 0.720 |
Why?
| Transplantation Conditioning | 1 | 2019 | 86 | 0.690 |
Why?
| Benzeneacetamides | 1 | 2019 | 9 | 0.690 |
Why?
| Glutaminase | 1 | 2019 | 14 | 0.690 |
Why?
| Glutamine | 2 | 2019 | 168 | 0.660 |
Why?
| Mice | 20 | 2024 | 6413 | 0.650 |
Why?
| Animals | 31 | 2024 | 14385 | 0.640 |
Why?
| Carnitine | 3 | 2014 | 86 | 0.630 |
Why?
| Lung | 1 | 2021 | 507 | 0.630 |
Why?
| Complex Mixtures | 2 | 2014 | 7 | 0.580 |
Why?
| Mitochondria, Liver | 1 | 2017 | 86 | 0.570 |
Why?
| Enzyme Inhibitors | 3 | 2019 | 446 | 0.560 |
Why?
| Warfarin | 5 | 2018 | 87 | 0.550 |
Why?
| Humans | 48 | 2024 | 54284 | 0.550 |
Why?
| Anti-Inflammatory Agents, Non-Steroidal | 3 | 2021 | 142 | 0.540 |
Why?
| Molecular Structure | 7 | 2020 | 319 | 0.520 |
Why?
| Deoxyguanosine | 3 | 2009 | 32 | 0.520 |
Why?
| Lymph Nodes | 1 | 2017 | 284 | 0.520 |
Why?
| Pyrrolidines | 3 | 2011 | 88 | 0.520 |
Why?
| Oxidative Stress | 3 | 2017 | 958 | 0.510 |
Why?
| Valerates | 2 | 2011 | 31 | 0.500 |
Why?
| Alkanes | 1 | 2014 | 9 | 0.490 |
Why?
| Carcinoma, Squamous Cell | 1 | 2017 | 384 | 0.470 |
Why?
| Mass Spectrometry | 7 | 2021 | 313 | 0.460 |
Why?
| Deficiency Diseases | 2 | 2012 | 16 | 0.460 |
Why?
| Cytochrome P-450 CYP3A | 3 | 2021 | 82 | 0.460 |
Why?
| Adenocarcinoma | 1 | 2017 | 428 | 0.450 |
Why?
| Environmental Pollutants | 1 | 2014 | 101 | 0.440 |
Why?
| Peptides | 3 | 2009 | 276 | 0.440 |
Why?
| Benzo(a)pyrene | 2 | 2003 | 38 | 0.440 |
Why?
| Carcinogens, Environmental | 1 | 2012 | 36 | 0.440 |
Why?
| Occupational Exposure | 2 | 2011 | 129 | 0.430 |
Why?
| Biotinidase Deficiency | 1 | 2011 | 1 | 0.420 |
Why?
| Egg White | 1 | 2011 | 6 | 0.420 |
Why?
| Mutagenesis | 2 | 2009 | 77 | 0.410 |
Why?
| Diphenylamine | 2 | 2021 | 5 | 0.410 |
Why?
| Air Pollutants, Occupational | 1 | 2011 | 18 | 0.410 |
Why?
| Breath Tests | 2 | 2009 | 44 | 0.400 |
Why?
| Anticoagulants | 4 | 2018 | 270 | 0.400 |
Why?
| Environmental Exposure | 1 | 2012 | 205 | 0.390 |
Why?
| Female | 23 | 2021 | 28441 | 0.350 |
Why?
| Hot Temperature | 1 | 2009 | 199 | 0.330 |
Why?
| Exhalation | 1 | 2008 | 19 | 0.320 |
Why?
| Rats | 12 | 2013 | 3415 | 0.320 |
Why?
| Proteomics | 1 | 2009 | 343 | 0.280 |
Why?
| Cell Line, Tumor | 4 | 2024 | 1550 | 0.280 |
Why?
| Male | 20 | 2019 | 27334 | 0.260 |
Why?
| Globins | 1 | 2004 | 14 | 0.260 |
Why?
| Reproducibility of Results | 5 | 2012 | 1304 | 0.260 |
Why?
| Stereoisomerism | 3 | 2020 | 106 | 0.240 |
Why?
| Styrene | 3 | 2013 | 10 | 0.240 |
Why?
| Oligodendroglioma | 1 | 2023 | 10 | 0.230 |
Why?
| Astrocytoma | 1 | 2023 | 21 | 0.230 |
Why?
| Nitrosamines | 1 | 2003 | 8 | 0.230 |
Why?
| Dose-Response Relationship, Drug | 3 | 2021 | 1476 | 0.230 |
Why?
| Cell Line | 3 | 2021 | 1153 | 0.230 |
Why?
| Kinetics | 7 | 2021 | 692 | 0.220 |
Why?
| Cross-Linking Reagents | 3 | 2008 | 42 | 0.220 |
Why?
| Isothiocyanates | 1 | 2003 | 25 | 0.220 |
Why?
| Glioma | 1 | 2023 | 78 | 0.220 |
Why?
| Genotype | 3 | 2020 | 599 | 0.210 |
Why?
| Glucuronosyltransferase | 2 | 2014 | 157 | 0.210 |
Why?
| Carcinoma, Non-Small-Cell Lung | 1 | 2024 | 164 | 0.210 |
Why?
| Rats, Inbred F344 | 6 | 2013 | 209 | 0.200 |
Why?
| Antineoplastic Agents | 3 | 2024 | 1300 | 0.200 |
Why?
| Aryl Hydrocarbon Hydroxylases | 2 | 2012 | 70 | 0.200 |
Why?
| Meclofenamic Acid | 1 | 2020 | 4 | 0.200 |
Why?
| Phenotype | 2 | 2021 | 820 | 0.200 |
Why?
| RNA Processing, Post-Transcriptional | 1 | 2021 | 29 | 0.190 |
Why?
| Sensitivity and Specificity | 4 | 2011 | 923 | 0.190 |
Why?
| Surface Properties | 1 | 2020 | 79 | 0.190 |
Why?
| Particle Size | 1 | 2020 | 88 | 0.190 |
Why?
| Indazoles | 1 | 2020 | 55 | 0.190 |
Why?
| Lipid Metabolism | 1 | 2021 | 194 | 0.190 |
Why?
| Adamantane | 1 | 2020 | 33 | 0.190 |
Why?
| Metabolic Networks and Pathways | 1 | 2020 | 104 | 0.180 |
Why?
| Plasmids | 1 | 2020 | 180 | 0.180 |
Why?
| Nucleic Acid Conformation | 3 | 2011 | 99 | 0.180 |
Why?
| Brain Neoplasms | 1 | 2023 | 284 | 0.180 |
Why?
| Substrate Specificity | 3 | 2021 | 209 | 0.180 |
Why?
| Inhalation Exposure | 4 | 2010 | 34 | 0.180 |
Why?
| Proteins | 1 | 2003 | 376 | 0.180 |
Why?
| Transplantation, Homologous | 1 | 2019 | 155 | 0.180 |
Why?
| Paraventricular Hypothalamic Nucleus | 1 | 2019 | 9 | 0.170 |
Why?
| Leukemia | 1 | 2019 | 69 | 0.170 |
Why?
| High-Throughput Nucleotide Sequencing | 1 | 2021 | 206 | 0.170 |
Why?
| Models, Molecular | 3 | 2019 | 423 | 0.170 |
Why?
| Cannabinoids | 1 | 2020 | 108 | 0.170 |
Why?
| Computational Biology | 1 | 2021 | 231 | 0.170 |
Why?
| Lymphoma | 1 | 2019 | 72 | 0.170 |
Why?
| Organoplatinum Compounds | 3 | 2011 | 18 | 0.170 |
Why?
| Basic Helix-Loop-Helix Transcription Factors | 1 | 2019 | 44 | 0.170 |
Why?
| Hypoxanthine Phosphoribosyltransferase | 4 | 2011 | 21 | 0.170 |
Why?
| Stem Cell Transplantation | 1 | 2019 | 196 | 0.160 |
Why?
| Software | 1 | 2021 | 296 | 0.160 |
Why?
| Xenograft Model Antitumor Assays | 1 | 2019 | 219 | 0.160 |
Why?
| Adenosine | 2 | 2009 | 71 | 0.160 |
Why?
| Mutation | 7 | 2023 | 1501 | 0.160 |
Why?
| Middle Aged | 5 | 2019 | 13088 | 0.160 |
Why?
| Kynurenine | 1 | 2017 | 17 | 0.160 |
Why?
| Glutathione Disulfide | 1 | 2017 | 45 | 0.160 |
Why?
| Repressor Proteins | 1 | 2019 | 165 | 0.150 |
Why?
| Electron Transport Complex III | 1 | 2017 | 12 | 0.150 |
Why?
| Inhibitory Concentration 50 | 2 | 2014 | 80 | 0.150 |
Why?
| Aged | 4 | 2019 | 10054 | 0.150 |
Why?
| Computer Simulation | 1 | 2018 | 332 | 0.150 |
Why?
| Succinate Dehydrogenase | 1 | 2017 | 28 | 0.150 |
Why?
| Electron Transport Complex IV | 1 | 2017 | 45 | 0.150 |
Why?
| Diet, High-Fat | 1 | 2019 | 216 | 0.150 |
Why?
| Biopsy, Needle | 1 | 2017 | 195 | 0.150 |
Why?
| Models, Biological | 2 | 2018 | 823 | 0.140 |
Why?
| Electron Transport Complex I | 1 | 2017 | 42 | 0.140 |
Why?
| Young Adult | 3 | 2019 | 4318 | 0.140 |
Why?
| DNA Copy Number Variations | 1 | 2017 | 114 | 0.140 |
Why?
| Nitrophenols | 2 | 2013 | 15 | 0.140 |
Why?
| Reactive Oxygen Species | 2 | 2017 | 491 | 0.140 |
Why?
| Sex Characteristics | 3 | 2006 | 214 | 0.140 |
Why?
| Adult | 6 | 2019 | 14207 | 0.140 |
Why?
| Sulfides | 1 | 2016 | 32 | 0.140 |
Why?
| X-Rays | 1 | 2016 | 57 | 0.140 |
Why?
| Cystic Fibrosis | 2 | 2009 | 157 | 0.140 |
Why?
| Glucose | 2 | 2008 | 366 | 0.130 |
Why?
| DNA, Mitochondrial | 1 | 2017 | 186 | 0.130 |
Why?
| Neurons | 1 | 2019 | 486 | 0.130 |
Why?
| DNA Damage | 4 | 2009 | 357 | 0.130 |
Why?
| Neoplasm Staging | 1 | 2017 | 806 | 0.130 |
Why?
| Amino Acid Sequence | 2 | 2007 | 767 | 0.120 |
Why?
| Hazardous Substances | 1 | 2014 | 16 | 0.120 |
Why?
| Reference Standards | 2 | 2011 | 63 | 0.120 |
Why?
| Calibration | 2 | 2011 | 59 | 0.120 |
Why?
| Aromatase Inhibitors | 1 | 2013 | 15 | 0.110 |
Why?
| Gas Chromatography-Mass Spectrometry | 2 | 2003 | 70 | 0.110 |
Why?
| Methylmalonyl-CoA Decarboxylase | 1 | 2012 | 6 | 0.110 |
Why?
| Carbon-Carbon Ligases | 1 | 2012 | 8 | 0.110 |
Why?
| Glutarates | 1 | 2012 | 6 | 0.110 |
Why?
| Acetyl-CoA Carboxylase | 1 | 2012 | 17 | 0.110 |
Why?
| Carbon-Nitrogen Ligases | 1 | 2012 | 15 | 0.110 |
Why?
| Nitriles | 1 | 2013 | 69 | 0.110 |
Why?
| Triazoles | 1 | 2013 | 120 | 0.110 |
Why?
| Lipid Peroxidation | 2 | 2009 | 132 | 0.100 |
Why?
| Platinum | 1 | 2011 | 13 | 0.100 |
Why?
| Pentanes | 1 | 2011 | 2 | 0.100 |
Why?
| Deoxyadenosines | 1 | 2011 | 5 | 0.100 |
Why?
| Adenosine Monophosphate | 2 | 2009 | 15 | 0.100 |
Why?
| Aged, 80 and over | 2 | 2017 | 3431 | 0.100 |
Why?
| Base Pairing | 1 | 2011 | 28 | 0.100 |
Why?
| Hemiterpenes | 1 | 2011 | 10 | 0.100 |
Why?
| Mice, Inbred C57BL | 3 | 2012 | 1999 | 0.100 |
Why?
| Gene Expression Regulation, Enzymologic | 1 | 2013 | 206 | 0.100 |
Why?
| Erythrocytes | 1 | 2011 | 98 | 0.100 |
Why?
| Creatinine | 1 | 2011 | 169 | 0.100 |
Why?
| Urea | 2 | 2009 | 83 | 0.100 |
Why?
| Leucine | 1 | 2011 | 113 | 0.100 |
Why?
| Outpatients | 1 | 2011 | 123 | 0.100 |
Why?
| Cost-Benefit Analysis | 1 | 2011 | 291 | 0.090 |
Why?
| Freezing | 1 | 2009 | 15 | 0.090 |
Why?
| Comet Assay | 1 | 2009 | 17 | 0.090 |
Why?
| F2-Isoprostanes | 1 | 2009 | 8 | 0.090 |
Why?
| Polymorphism, Single Nucleotide | 1 | 2013 | 552 | 0.090 |
Why?
| Hydantoins | 1 | 2009 | 2 | 0.090 |
Why?
| Ribonucleosides | 1 | 2009 | 2 | 0.090 |
Why?
| Chlorobenzoates | 1 | 2009 | 2 | 0.090 |
Why?
| Half-Life | 1 | 2009 | 92 | 0.090 |
Why?
| Molecular Sequence Data | 2 | 2011 | 980 | 0.090 |
Why?
| Hydrogen Peroxide | 1 | 2009 | 142 | 0.090 |
Why?
| Oxidants | 1 | 2009 | 64 | 0.090 |
Why?
| Species Specificity | 4 | 2013 | 205 | 0.090 |
Why?
| HeLa Cells | 1 | 2009 | 291 | 0.080 |
Why?
| Oxidation-Reduction | 4 | 2013 | 382 | 0.080 |
Why?
| Risk Assessment | 3 | 2010 | 1361 | 0.080 |
Why?
| Lymphocytes | 1 | 2009 | 168 | 0.080 |
Why?
| Magnetic Resonance Spectroscopy | 4 | 2011 | 253 | 0.080 |
Why?
| Dwarfism, Pituitary | 1 | 2008 | 4 | 0.080 |
Why?
| Formaldehyde | 1 | 2008 | 49 | 0.080 |
Why?
| Carboplatin | 2 | 2024 | 62 | 0.080 |
Why?
| Trichloroethylene | 1 | 2009 | 73 | 0.080 |
Why?
| Food Deprivation | 1 | 2007 | 29 | 0.080 |
Why?
| Toxicology | 1 | 2007 | 31 | 0.080 |
Why?
| Bronchi | 1 | 2008 | 51 | 0.080 |
Why?
| Pituitary Gland | 1 | 2008 | 78 | 0.080 |
Why?
| Structural Homology, Protein | 1 | 2007 | 9 | 0.080 |
Why?
| Liver | 3 | 2013 | 1225 | 0.070 |
Why?
| Chemical Industry | 1 | 2006 | 3 | 0.070 |
Why?
| Spiro Compounds | 1 | 2006 | 8 | 0.070 |
Why?
| Imines | 1 | 2006 | 15 | 0.070 |
Why?
| Manduca | 1 | 2006 | 1 | 0.070 |
Why?
| Ecdysteroids | 1 | 2006 | 1 | 0.070 |
Why?
| Hemolymph | 1 | 2006 | 5 | 0.070 |
Why?
| Binding Sites | 3 | 2013 | 440 | 0.070 |
Why?
| Histones | 1 | 2008 | 335 | 0.070 |
Why?
| Aldehydes | 1 | 2006 | 97 | 0.070 |
Why?
| Asthma | 1 | 2009 | 293 | 0.070 |
Why?
| Buthionine Sulfoximine | 1 | 2024 | 17 | 0.060 |
Why?
| Gene Expression Profiling | 2 | 2006 | 1138 | 0.060 |
Why?
| Chromosomes, Human, Pair 19 | 1 | 2023 | 10 | 0.060 |
Why?
| Rabbits | 1 | 2004 | 425 | 0.060 |
Why?
| T-Lymphocytes | 1 | 2006 | 373 | 0.060 |
Why?
| Isocitrate Dehydrogenase | 1 | 2023 | 21 | 0.060 |
Why?
| 7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide | 1 | 2003 | 12 | 0.060 |
Why?
| Chromosomes, Human, Pair 1 | 1 | 2023 | 113 | 0.060 |
Why?
| Acetaminophen | 1 | 2006 | 349 | 0.060 |
Why?
| Formamides | 1 | 2021 | 3 | 0.050 |
Why?
| Drug Resistance, Neoplasm | 1 | 2024 | 309 | 0.050 |
Why?
| Furans | 1 | 2021 | 27 | 0.050 |
Why?
| Halogenation | 1 | 2021 | 8 | 0.050 |
Why?
| Acetic Acid | 1 | 2021 | 12 | 0.050 |
Why?
| Quinones | 1 | 2021 | 11 | 0.050 |
Why?
| Mice, Inbred Strains | 2 | 2013 | 198 | 0.050 |
Why?
| Propionates | 1 | 2021 | 28 | 0.050 |
Why?
| Templates, Genetic | 1 | 2021 | 17 | 0.050 |
Why?
| Prospective Studies | 1 | 2008 | 2604 | 0.050 |
Why?
| RNA, Ribosomal | 1 | 2021 | 18 | 0.050 |
Why?
| Methyltransferases | 1 | 2021 | 28 | 0.050 |
Why?
| Biological Availability | 1 | 2021 | 131 | 0.050 |
Why?
| Nucleotide Motifs | 1 | 2021 | 29 | 0.050 |
Why?
| Adenine | 1 | 2021 | 44 | 0.050 |
Why?
| Benzoquinones | 1 | 2020 | 33 | 0.050 |
Why?
| RNA, Bacterial | 1 | 2021 | 58 | 0.050 |
Why?
| Cohort Studies | 2 | 2018 | 1543 | 0.050 |
Why?
| RNA, Fungal | 1 | 2021 | 30 | 0.050 |
Why?
| Neoplasms | 2 | 2008 | 1316 | 0.050 |
Why?
| Spectrometry, Fluorescence | 1 | 2020 | 53 | 0.050 |
Why?
| Meiosis | 1 | 2021 | 70 | 0.050 |
Why?
| Models, Chemical | 1 | 2020 | 65 | 0.050 |
Why?
| Aging | 1 | 2006 | 784 | 0.050 |
Why?
| Pyrimidines | 1 | 2021 | 196 | 0.050 |
Why?
| ROC Curve | 1 | 2021 | 259 | 0.050 |
Why?
| Sequence Analysis, DNA | 1 | 2021 | 273 | 0.050 |
Why?
| Recombinant Proteins | 2 | 2012 | 569 | 0.040 |
Why?
| Saccharomyces cerevisiae | 1 | 2021 | 218 | 0.040 |
Why?
| Biocatalysis | 1 | 2019 | 20 | 0.040 |
Why?
| Pro-Opiomelanocortin | 1 | 2019 | 10 | 0.040 |
Why?
| Transcription, Genetic | 1 | 2021 | 418 | 0.040 |
Why?
| Escherichia coli | 1 | 2021 | 250 | 0.040 |
Why?
| Child | 2 | 2009 | 7341 | 0.040 |
Why?
| Protein Binding | 2 | 2012 | 736 | 0.040 |
Why?
| Databases, Factual | 1 | 2021 | 684 | 0.040 |
Why?
| Mice, Knockout | 1 | 2021 | 926 | 0.040 |
Why?
| Cattle | 2 | 2009 | 224 | 0.040 |
Why?
| Protons | 2 | 2011 | 81 | 0.040 |
Why?
| Temperature | 2 | 2011 | 177 | 0.040 |
Why?
| Structure-Activity Relationship | 1 | 2018 | 423 | 0.040 |
Why?
| RNA, Messenger | 1 | 2021 | 1202 | 0.040 |
Why?
| Nuclear Magnetic Resonance, Biomolecular | 2 | 2007 | 34 | 0.030 |
Why?
| Pilot Projects | 1 | 2018 | 808 | 0.030 |
Why?
| Antifungal Agents | 1 | 2018 | 363 | 0.030 |
Why?
| Acyl Coenzyme A | 1 | 2014 | 8 | 0.030 |
Why?
| False Negative Reactions | 1 | 2014 | 36 | 0.030 |
Why?
| Hep G2 Cells | 1 | 2014 | 46 | 0.030 |
Why?
| Culture Media | 1 | 2014 | 100 | 0.030 |
Why?
| Sapogenins | 1 | 2013 | 4 | 0.030 |
Why?
| Hydrophobic and Hydrophilic Interactions | 1 | 2013 | 42 | 0.030 |
Why?
| Triazines | 1 | 2013 | 30 | 0.030 |
Why?
| Allosteric Regulation | 1 | 2012 | 14 | 0.030 |
Why?
| Pharmacogenetics | 1 | 2012 | 55 | 0.030 |
Why?
| Solutions | 1 | 2011 | 29 | 0.030 |
Why?
| Anticonvulsants | 1 | 2013 | 129 | 0.030 |
Why?
| Hydrogen Bonding | 1 | 2011 | 45 | 0.030 |
Why?
| Pyrazoles | 1 | 2012 | 110 | 0.030 |
Why?
| Amines | 1 | 2011 | 46 | 0.030 |
Why?
| Molecular Dynamics Simulation | 1 | 2011 | 40 | 0.030 |
Why?
| Isomerism | 1 | 2010 | 24 | 0.020 |
Why?
| Hydroxylation | 1 | 2010 | 61 | 0.020 |
Why?
| Biotransformation | 1 | 2010 | 100 | 0.020 |
Why?
| Drug Monitoring | 1 | 2011 | 85 | 0.020 |
Why?
| DNA-Formamidopyrimidine Glycosylase | 1 | 2009 | 2 | 0.020 |
Why?
| Obesity | 1 | 2019 | 1202 | 0.020 |
Why?
| Base Sequence | 1 | 2011 | 719 | 0.020 |
Why?
| Trichloroacetic Acid | 1 | 2009 | 8 | 0.020 |
Why?
| Dichloroacetic Acid | 1 | 2009 | 5 | 0.020 |
Why?
| Cysteine | 1 | 2009 | 62 | 0.020 |
Why?
| Respiratory Function Tests | 1 | 2009 | 98 | 0.020 |
Why?
| Chromogranin B | 1 | 2008 | 1 | 0.020 |
Why?
| Secretogranin II | 1 | 2008 | 1 | 0.020 |
Why?
| Peptide Mapping | 1 | 2008 | 22 | 0.020 |
Why?
| Adrenocorticotropic Hormone | 1 | 2008 | 34 | 0.020 |
Why?
| Mice, Mutant Strains | 1 | 2008 | 84 | 0.020 |
Why?
| Prolactin | 1 | 2008 | 43 | 0.020 |
Why?
| Thyrotropin | 1 | 2008 | 46 | 0.020 |
Why?
| Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 1 | 2008 | 79 | 0.020 |
Why?
| Oleic Acid | 1 | 2007 | 7 | 0.020 |
Why?
| Coumaric Acids | 1 | 2007 | 9 | 0.020 |
Why?
| Growth Hormone | 1 | 2008 | 78 | 0.020 |
Why?
| Glycogenolysis | 1 | 2007 | 9 | 0.020 |
Why?
| Genes, Reporter | 1 | 2007 | 98 | 0.020 |
Why?
| Longevity | 1 | 2008 | 87 | 0.020 |
Why?
| Lysine | 1 | 2008 | 102 | 0.020 |
Why?
| Protein Structure, Tertiary | 1 | 2008 | 289 | 0.020 |
Why?
| Insulin-Like Growth Factor I | 1 | 2008 | 137 | 0.020 |
Why?
| Nucleic Acid Heteroduplexes | 1 | 2007 | 5 | 0.020 |
Why?
| Immunity, Innate | 1 | 2008 | 114 | 0.020 |
Why?
| Peptide Fragments | 1 | 2008 | 242 | 0.020 |
Why?
| Epidemiologic Studies | 1 | 2007 | 30 | 0.020 |
Why?
| Pregnancy | 1 | 2014 | 2620 | 0.020 |
Why?
| Benzene | 1 | 2006 | 6 | 0.020 |
Why?
| Czech Republic | 1 | 2006 | 5 | 0.020 |
Why?
| Toluene | 1 | 2006 | 9 | 0.020 |
Why?
| Sister Chromatid Exchange | 1 | 2006 | 14 | 0.020 |
Why?
| Molecular Epidemiology | 1 | 2006 | 36 | 0.020 |
Why?
| Fatty Acids | 1 | 2007 | 174 | 0.020 |
Why?
| Mutagenicity Tests | 1 | 2006 | 56 | 0.020 |
Why?
| Clone Cells | 1 | 2006 | 89 | 0.020 |
Why?
| Mutant Proteins | 1 | 2006 | 41 | 0.020 |
Why?
| Aorta | 1 | 2007 | 177 | 0.020 |
Why?
| Triglycerides | 1 | 2007 | 195 | 0.020 |
Why?
| Microchemistry | 1 | 2006 | 6 | 0.020 |
Why?
| Confidence Intervals | 1 | 2006 | 167 | 0.020 |
Why?
| Mutagens | 1 | 2006 | 81 | 0.020 |
Why?
| Larva | 1 | 2006 | 23 | 0.020 |
Why?
| Acetylcysteine | 1 | 2006 | 118 | 0.020 |
Why?
| Predictive Value of Tests | 1 | 2009 | 1048 | 0.020 |
Why?
| Spleen | 1 | 2006 | 186 | 0.020 |
Why?
| Body Composition | 1 | 2007 | 349 | 0.020 |
Why?
| Chromosome Aberrations | 1 | 2006 | 316 | 0.020 |
Why?
| Oxygen | 1 | 2007 | 361 | 0.020 |
Why?
| Cross-Sectional Studies | 1 | 2009 | 1693 | 0.010 |
Why?
| Rats, Sprague-Dawley | 1 | 2006 | 1663 | 0.010 |
Why?
| Time Factors | 1 | 2009 | 3213 | 0.010 |
Why?
| Signal Transduction | 1 | 2009 | 1753 | 0.010 |
Why?
| Child, Preschool | 1 | 2009 | 4147 | 0.010 |
Why?
| Adolescent | 1 | 2009 | 6897 | 0.010 |
Why?
|
|
Boysen's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Derived automatically based on a person's publications. Keywords from attributed publications are matched to keywords from the MeSH. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|